☆Elmind Capital, LP
Quality Q
0.294
AUM ($M)
398
Positions
35
Turnover
0.26
Top-10 wt
67%
Herfindahl
0.059
History (qtrs)
3
Excess Return
—
AI Eval Run AI Eval
Holdings · 40 positions · portfolio value $398M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆COGT funds › | COGENT BIOSCIENCES INC | HOLD | — | 11.4% | -1.4% | 45.3 | 1,170,740 | +0 | 2 | — |
| ☆SNDX funds › | SYNDAX PHARMACEUTICALS INC | HOLD | — | 10.2% | -2.1% | 40.6 | 1,855,000 | +0 | 2 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC NEW | ADD | — | 9.3% | +1.5% | 36.8 | 990,000 | +125,000 | 2 | — |
| ☆RLAY funds › | RELAY THERAPEUTICS INC | ADD | — | 6.9% | +5.4% | 27.4 | 1,465,279 | +928,333 | 2 | — |
| ☆PCVX funds › | VAXCYTE INC | ADD | — | 6.6% | +1.4% | 26.3 | 452,340 | +135,840 | 2 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | TRIM | — | 4.7% | -0.8% | 18.7 | 436,518 | -45,982 | 2 | — |
| ☆PHVS funds › | PHARVARIS N V | ADD | — | 4.6% | +0.8% | 18.2 | 525,750 | +50,000 | 2 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | ADD | — | 4.5% | +1.6% | 18.1 | 984,931 | +450,000 | 2 | — |
| ☆CTMX funds › | CYTOMX THERAPEUTICS INC. | HOLD | — | 4.3% | -1.8% | 17.1 | 4,550,000 | +0 | 2 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | ADD | — | 4.2% | +2.7% | 16.6 | 292,600 | +115,000 | 2 | — |
| ☆LEGN funds › | LEGEND BIOTECH CORP | NEW | — | 4.1% | +4.1% | 16.5 | 570,569 | +570,569 | 1 | — |
| ☆BEAM funds › | BEAM THERAPEUTICS INC | HOLD | — | 4.1% | +0.9% | 16.3 | 476,338 | +0 | 2 | — |
| ☆CGEM funds › | CULLINAN THERAPEUTICS INC | ADD | — | 3.2% | +1.0% | 12.6 | 690,000 | +160,000 | 2 | — |
| ☆NRIX funds › | NURIX THERAPEUTICS INC | HOLD | — | 2.8% | +0.8% | 11.2 | 460,000 | +0 | 2 | — |
| ☆KRYS funds › | KRYSTAL BIOTECH INC | HOLD | — | 2.1% | +0.4% | 8.2 | 22,000 | +0 | 2 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP DEL | HOLD | — | 2.0% | -0.5% | 8.1 | 15,000 | +0 | 2 | — |
| ☆SMMT funds › | SUMMIT THERAPEUTICS INC | NEW | — | 1.8% | +1.8% | 7.2 | 493,820 | +493,820 | 1 | — |
| ☆INSM funds › | INSMED INC | NEW | — | 1.7% | +1.7% | 6.9 | 65,000 | +65,000 | 1 | — |
| ☆BCRX funds › | BIOCRYST PHARMACEUTICALS INC | TRIM | — | 1.3% | -1.4% | 5.2 | 520,000 | -480,000 | 2 | — |
| ☆MBX funds › | MBX BIOSCIENCES INC | TRIM | — | 1.3% | -0.5% | 5.0 | 91,000 | -120,000 | 2 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | HOLD | — | 1.2% | +0.0% | 4.7 | 38,000 | +0 | 2 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | TRIM | — | 1.1% | -0.0% | 4.4 | 120,000 | -100,000 | 2 | — |
| ☆DBVT funds › | DBV TECHNOLOGIES S A | HOLD | — | 1.1% | -0.5% | 4.3 | 265,000 | +0 | 2 | — |
| ☆ALMS funds › | ALUMIS INC | HOLD | — | 0.9% | +0.1% | 3.7 | 130,000 | +0 | 2 | — |
| ☆SUPN funds › | SUPERNUS PHARMACEUTICALS | ADD | — | 0.8% | +0.5% | 3.3 | 70,000 | +50,000 | 2 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | HOLD | — | 0.7% | -0.1% | 2.7 | 47,000 | +0 | 2 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | ADD | — | 0.6% | +0.1% | 2.6 | 81,143 | +22,895 | 2 | — |
| ☆AMLX funds › | AMYLYX PHARMACEUTICALS INC | HOLD | — | 0.5% | +0.1% | 2.0 | 112,000 | +0 | 2 | — |
| ☆ALEC funds › | ALECTOR INC | HOLD | — | 0.5% | -0.1% | 1.8 | 900,000 | +0 | 2 | — |
| ☆SEPN funds › | SEPTERNA INC | NEW | — | 0.4% | +0.4% | 1.7 | 49,444 | +49,444 | 1 | — |
| ☆DSGN funds › | DESIGN THERAPEUTICS INC | TRIM | — | 0.4% | -0.2% | 1.6 | 107,900 | -100,000 | 2 | — |
| ☆STRO funds › | SUTRO BIOPHARMA INC | NEW | — | 0.3% | +0.3% | 1.1 | 32,037 | +32,037 | 1 | — |
| ☆WVE funds › | WAVE LIFE SCIENCES LTD | HOLD | — | 0.3% | -0.1% | 1.0 | 177,846 | +0 | 2 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | TRIM | — | 0.2% | -3.6% | 0.6 | 20,000 | -330,000 | 2 | — |
| ☆ENGN funds › | ENGENE THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.4 | 210,000 | +210,000 | 1 | — |
| ☆CUSIP:03753U106 funds › | APELLIS PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -50,000 | 0 | — |
| ☆CUSIP:29286M105 funds › | ENGENE HOLDINGS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -210,000 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -5.8% | 0.0 | 0 | -1,021,300 | 0 | — |
| ☆CGON funds › | CG ONCOLOGY INC | EXIT | — | 0.0% | -5.6% | 0.0 | 0 | -291,800 | 0 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -10,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 398 | 35 | 0.26 | 67% | 0.059 | 0.294 | — | in |
| 2026Q1 | 352 | 34 | 0.18 | 69% | 0.062 | 0.471 | — | entered |
| 2025Q4 | 339 | 34 | 0.00 | 69% | 0.062 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status